2.80 USD
▲+0.02+7.69%
盘后 2.58 -0.60%
2026-08-03
市值
$37.87M
市盈率
—
EPS
-3.27
股息率
—
52 周区间
2.13 – 11.25
成交量
680.69K
Beta
-4.42
目标价
19.50
52W 低 2.1352W 高 11.25
价格走势
公司简介
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38α. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant...